Should Basket Trials Be Pathways to Drug Registration for Biomarker-Defined Subgroups of Advanced Cancers?

J Clin Oncol. 2021 Aug 1;39(22):2426-2429. doi: 10.1200/JCO.21.00552. Epub 2021 May 12.

Authors

Kelvin K-W Chan¹, Ian F Tannock²

Affiliations

¹ Sunnybrook Research Institute & Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
² Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

PMID: 33979191
DOI: 10.1200/JCO.21.00552

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor
Humans
Neoplasms* / drug therapy
Pharmaceutical Preparations*

Substances

Biomarkers, Tumor
Pharmaceutical Preparations